← Open Payments lookup

JORGE RAICHMAN: Open Payments

NPI 1093740979 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,327 in 41 payments from 9 companies in 2025. Trend: 2023 $2,882 · 2024 $1,535 · 2025 $1,327

Food & beverage: $1,327
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.14$499
Janssen Pharmaceuticals, Inc6$292
Alkermes, Inc.8$201
Teva Pharmaceuticals USA, Inc.4$156
Otsuka America Pharmaceutical, Inc.3$63
Vanda Pharmaceuticals Inc.3$47
Lundbeck LLC1$29
ABBVIE INC.1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19

Products named: COBENFY, INVEGA, ARISTADA, INVEGA SUSTENNA, AUSTEDO XR, REXULTI, UZEDY, FANAPT.

Industry payments across TX — which companies pay providers there.